| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/26/1992 | US5116725 Colorimetric, diagnosis |
| 05/26/1992 | US5116724 Products for separation applicable to cells in the immunopurification field |
| 05/26/1992 | US5116612 Immunotherapy agents for treatment of IgE mediated allergies |
| 05/26/1992 | US5116596 Process for the preparation of an organ-specific substance labeled with technetium-99m |
| 05/26/1992 | CA1301677C Recombinant surface antigens of swine mycoplasma and vaccines and diagnostics based on them |
| 05/26/1992 | CA1301674C Pseudorabies virus recombinants and their use in the production of proteins |
| 05/26/1992 | CA1301644C Antibodies against (2'-5')oligo a synthetase, their use for immunoassays of this interferon-induced enzyme and of its different subtypes |
| 05/21/1992 | CA2096633A1 Measles virus recombinant poxvirus vaccine |
| 05/21/1992 | CA2055813A1 Cyclosporin immunoassay |
| 05/20/1992 | EP0486170A1 Baculoviral expression system comprising procaryotic leader sequence |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0485961A1 Oncostatin M for stimulating LDL uptake and LDL receptor expression |
| 05/20/1992 | EP0485749A2 Chemical modification of antibodies for creating of immunoconjugates |
| 05/20/1992 | EP0485701A1 Insertion of DNA by modified transposons |
| 05/20/1992 | EP0485664A1 Method of preparing a diagnostic agent for detecting inflammations |
| 05/20/1992 | EP0485652A1 Process to prepare vaccines against pathologic agents |
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485430A1 Methods and compositions for ameliorating the symptoms of sepsis |
| 05/20/1992 | EP0485380A1 Immunological use of microwaves |
| 05/20/1992 | EP0258404B1 Method of detecting antibody against htlv-iii |
| 05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
| 05/19/1992 | US5114953 Peptides |
| 05/19/1992 | US5114943 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 05/19/1992 | US5114847 Fusion with cytoplasm from transformed cells; hybridomas |
| 05/19/1992 | US5114844 Immunoassay with a protein or antibody |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114721 Lymphocytes activated by exposure to antigen and surface treated with photoactive psoralen crosslinking agent |
| 05/19/1992 | US5114713 P. falciparum cs-peptides as universal t-cell epitope |
| 05/19/1992 | US5114712 Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection |
| 05/19/1992 | CA1301066C Anti-tumour substance and process for producing the same |
| 05/19/1992 | CA1301065C Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies |
| 05/19/1992 | CA1301064C Immunomodulating compositions and their use |
| 05/19/1992 | CA1301063C Biologically degradable superparamagnetic materials for use in clinicalapplications |
| 05/17/1992 | WO1992008786A1 Human rotaviruses, vaccines and methods |
| 05/16/1992 | CA2048078A1 Chemical modification of antibodies for creation of immunoconjugates |
| 05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
| 05/14/1992 | WO1992008492A1 Method of preparing a diagnostic agent for detecting inflammations |
| 05/14/1992 | WO1992008485A1 Diagnostic testing for campylobacter jejuni or coli infection using antigens |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007950A1 Method of gene transfer using retrotransposons |
| 05/14/1992 | WO1992007941A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | WO1992007940A2 Bovine respiratory syncytial virus genes |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007872A1 Tenascin related peptides |
| 05/14/1992 | WO1992007584A1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 05/14/1992 | WO1992007576A1 Protective four amino acid epitope against plasmodium vivax malaria |
| 05/14/1992 | WO1992007575A1 Antimicrobial composition |
| 05/14/1992 | WO1992004014A3 Regulation of neoplastic cell proliferation via a novel 5ht1a receptor |
| 05/14/1992 | WO1992002621A3 Allergens of alder pollen and applications thereof |
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | CA2096016A1 Diagnostic testing for campylobacter jejuni or coli injection using antigens |
| 05/14/1992 | CA2095356A1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2095145A1 Method of preparing a diagnostic agent for detecting inflammations |
| 05/14/1992 | CA2094916A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | CA2072581A1 Method of gene transfer using retrotransposons |
| 05/14/1992 | CA2055122A1 Methods for stimulating ldl uptake and ldl receptor expression |
| 05/13/1992 | EP0485361A1 Pre-S gene codes peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 05/13/1992 | EP0485209A1 Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides |
| 05/13/1992 | EP0484870A2 Prodrugs for beta-lactamase and uses thereof |
| 05/13/1992 | EP0484787A2 HCV-specific peptides, process for obtaining them and their use |
| 05/13/1992 | EP0484621A2 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 05/13/1992 | EP0484452A1 Fibulin |
| 05/13/1992 | EP0484403A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
| 05/13/1992 | EP0484396A1 Avipox virus promoters |
| 05/13/1992 | EP0260280B1 Immunoselection method |
| 05/12/1992 | US5112954 Antibodies specific for cancer cells |
| 05/12/1992 | US5112951 Separation of anti-metal chelate antibodies |
| 05/12/1992 | US5112756 Continuous production of bovine Maedi-Visna-like viral antigens in Cf2Th cells |
| 05/12/1992 | US5112754 Tissue plasminogen-activating factor and nonoclonal antibody |
| 05/12/1992 | US5112749 Recombinant DNA sequences for attenuated bacterium, Salmonella or Shigella and epitopes |
| 05/12/1992 | US5112748 Hybrid cells producing an antigen characteristic of the hepatitis b virus obtained from hepatocytes and established monkey cells, a process for obtaining these hybrid cells and their application to the production of the aforesaid antigen |
| 05/12/1992 | US5112607 Potentiation of immunotoxin action by Brefeldin A |
| 05/12/1992 | US5112606 Method of producing antibodies using colloidal metal as carrier |
| 05/12/1992 | CA1300506C Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives |
| 05/12/1992 | CA1300503C Immunological adjuvant |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/09/1992 | WO1992008488A1 Mycobacterium as adjuvant for antigens |
| 05/09/1992 | CA2055149A1 Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides |
| 05/08/1992 | WO1992008795A1 Expression of malaria polypeptides |
| 05/08/1992 | CA2095540A1 Expression of malaria polypeptides |
| 05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
| 05/07/1992 | DE4034982A1 New peptide(s) corresponding to part of HCV C-100-3 construct - useful in vaccines and in binding assays, e.g. to distinguish between acute and chronic infection |
| 05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2095428A1 Test for virulent revertants in attenuated live vaccines |
| 05/07/1992 | CA2055062A1 Prodrugs for beta-lactamase and uses thereof |
| 05/06/1992 | WO1992007580A1 Therapeutic uses of melanin |
| 05/06/1992 | WO1992007466A1 Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents |
| 05/06/1992 | EP0484148A1 A method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis and thus formulated medicines |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483911A2 Chicken anemia virus vaccine and diagnostic reagent |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0299082B1 Antiviral agent |
| 05/06/1992 | CN1060871A Novel onco-fetal gene, gene product and uses therefor |
| 05/06/1992 | CA2095141A1 Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents |
| 05/05/1992 | US5110908 Haemophilus influenzae peptides and proteins |
| 05/05/1992 | US5110794 Method of immunization with partially cationized substances and said partially cationized substances |
| 05/05/1992 | US5110738 Genetic engineering; hybridomas of melanoma and spleen cells |
| 05/05/1992 | US5110589 Antigen from surface of Treponema hyodysenteriae |